Curian Capital’s DexCom DXCM Stock Holding History

Curian Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-62,452	Closed	-$1.28M	–	105
2015 Q4	$1.28M	Sell	62,452 -86,616	-58%	-$1.8M	0.09%	210
2015 Q3	$3.2M	Buy	+149,068	New	+$3.33M	0.09%	234

Other funds holding DXCM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Curian Capital's DXCM Position: Q1 2016 in Review

Curian Capital sold out of DexCom (DXCM) in Q1 2016, closing a stake of 62,452 shares — an estimated $1.28M sold.

Curian Capital first reported a position in DXCM in Q3 2015 and held it in 2 quarters. The position peaked at $3.2M in Q3 2015. 263 funds tracked by Wall St. Rank hold DXCM as of Q1 2016.

Curian Capital reported no remaining DexCom position as of Q1 2016 after selling out during the quarter.
Curian Capital sold 62,452 DexCom shares in Q1 2016, an estimated $1.28M.
Curian Capital first reported a position in DexCom in Q3 2015 and held it in 2 quarters.
Curian Capital's DexCom position peaked at $3.2M in Q3 2015.
263 funds tracked by Wall St. Rank held DexCom as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.